MAPK signaling to the early secretory pathway revealed by kinase/phosphatase functional screening

To what extent the secretory pathway is regulated by cellular signaling is unknown. In this study, we used RNA interference to explore the function of human kinases and phosphatases in controlling the organization of and trafficking within the secretory pathway. We identified 122 kinases/phosphatase...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 189; no. 6; pp. 997 - 1011
Main Authors Farhan, Hesso, Wendeler, Markus W, Mitrovic, Sandra, Fava, Eugenio, Silberberg, Yael, Sharan, Roded, Zerial, Marino, Hauri, Hans-Peter
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 14.06.2010
Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To what extent the secretory pathway is regulated by cellular signaling is unknown. In this study, we used RNA interference to explore the function of human kinases and phosphatases in controlling the organization of and trafficking within the secretory pathway. We identified 122 kinases/phosphatases that affect endoplasmic reticulum (ER) export, ER exit sites (ERESs), and/or the Golgi apparatus. Numerous kinases/phosphatases regulate the number of ERESs and ER to Golgi protein trafficking. Among the pathways identified, the Raf-MEK (MAPK/ERK [extracellular signal-regulated kinase] kinase)-ERK cascade, including its regulatory proteins CNK1 (connector enhancer of the kinase suppressor of Ras-1) and neurofibromin, controls the number of ERESs via ERK2, which targets Sec16, a key regulator of ERESs and COPII (coat protein II) vesicle biogenesis. Our analysis reveals an unanticipated complexity of kinase/phosphatase-mediated regulation of the secretory pathway, uncovering a link between growth factor signaling and ER export.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
E. Fava’s present address is German Center for Neurodegenerative Diseases, D-53175 Bonn, Germany.
ISSN:0021-9525
1540-8140
1540-8140
DOI:10.1083/jcb.200912082